| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000028354 |
| Receipt No. | R000032455 |
| Official scientific title of the study | A study to investigate systemic absorption of health food: a cross over study |
| Date of disclosure of the study information | 2017/07/25 |
| Last modified on | 2018/05/01 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | A study to investigate systemic absorption of health food: a cross over study | |
| Title of the study (Brief title) | A study for systemic absorption of health food | |
| Region |
|
|
| Condition | |||
| Condition | None | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aim of this study is to assess differences in systemic absorption after ingestion of collagen peptide-containing beverages and collagen containing food in cross over study. |
| Basic objectives2 | Pharmacokinetics |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Blood hydroxyproline AUC and Cmax |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of study food substance (Once). | |
| Interventions/Control_2 | Ingestion of control food substance(1) (Once). | |
| Interventions/Control_3 | Ingestion of control food substance(2)(Once). | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Subjects who is healthy without any medications for serious disorders.
2)Subjects who gives consent in writing with full understanding of this study aim and contents |
|||
| Key exclusion criteria | 1) Subjects who is potential allergy to food
2) Subjects who has difficulties to participate this study due to hepatic, kidney, cardiac disorders, breathing disorder, endocrine disorder, metabolic defect, consciousness disturbance, diabetes, and other disorders. 3) Subjects who is under medication 4) Subjects who is on health food and supplements (including foods for specified health use, foods with functions claims and foods with nutrients function claims) that potentially influence the outcome of this study (Except subjects who can pause ingesting them at the point of informed consent) 5) Subjects who is under other study or within 4 weeks of termination of other study 6) Heavy smoker and heavy drinker 7) Subjects who is ineligible for this study due to physician's judgment |
|||
| Target sample size | 7 | |||
| Research contact person | |
| Name of lead principal investigator | Sadao Mori |
| Organization | MORINAGA&CO., LTD. |
| Division name | Health Business Headquarters. R&D Department Reserch Planning Group |
| Address | 2-1-1 Shimosueyoshi Tsurumi-ku ,Yokohama-Shi,Kanagawa,Japan |
| TEL | 070-3864-8266 |
| s-mori-ab@morinaga.co.jp | |
| Public contact | |
| Name of contact person | Shigeru Imai |
| Organization | CROee.INC |
| Division name | Evidence Division |
| Address | 2F YS Build. 1-13-23 Minamiikebukuro Toshima-ku, Tokyo, Japan |
| TEL | 03-5953-2108 |
| Homepage URL | |
| imai@croee.com | |
| Sponsor | |
| Institute | CROee.INC |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MORINAGA&CO., LTD |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京センタークリニック(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032455 |